Perioperative Beta Blockade
Perioperative Beta Blockade
复制标题
围手术期β阻断
DOI：
10.1055/s-0033-1351131
复制
发表时间：
2013
影响因子：
1.4
通讯作者：
J. Irani
中科院分区：
文献类型：
--
作者：
J. Irani
术前β受体阻滞剂的使用经历了几次变化，很明显，需要对该主题进行大型随机对照试验。目前，支持围手术期β阻滞的明智方法。建议患者在手术前继续使用β受体阻滞剂。接受大型结直肠手术、患有冠状动脉疾病或心脏病风险高的患者，应根据心率和血压滴定β受体阻滞剂。剂量应根据心率和血压进行滴定，而不是使用固定的长效剂量。当有β受体阻滞剂的适应症时，应在手术前数周开始使用。
Abstract The use of preoperative beta (β) blockade has been through several changes, and it is clear that large, randomized controlled trials on the subject are in need. Currently, a judicious approach to perioperative β blockade is supported. Continuation of β blockers is recommended for the patient taking them prior to surgery. Patients undergoing large colorectal procedures, with coronary artery disease or high cardiac risk, should have β blockers titrated to heart rate and blood pressure. Dosages should be titrated to heart rate and blood pressure rather than using fixed, long-acting dosages. When β blockers are indicated, they should be initiated weeks before surgery.
影响因子：
37.8
作者：
Lee, TH;Marcantonio, ER;Goldman, L
通讯作者：
Goldman, L